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Abstract
The objectives of this study were to describe the most recent pregnancy intentions and family 
planning preferences of HIV-infected and HIV-uninfected postpartum Malawian women, and to 
assess whether HIV status is associated with fertility desire and knowledge of intrauterine 
contraception (IUC) and the subdermal contraceptive implant. We conducted a cross-sectional 
analysis of the baseline characteristics of Malawian women enrolled in a prospective cohort study 
assessing postpartum contraceptive uptake and continuation. Women at a government hospital 
completed a baseline survey assessing reproductive history, family planning preferences, and 
knowledge of IUC and the implant. We used Pearson's chi-square tests to compare these 
parameters between HIV-infected and HIV-uninfected women. Modified Poisson regression was 
performed to assess the association between HIV status and fertility desire and knowledge about 
IUC and the implant. Of 634 postpartum women surveyed, HIV-infected women were more likely 
to report their most recent pregnancy was unintended (49% versus 37%, p=0.004). Nearly all 
women (97%) did not want a child in the next two years but HIV-infected women were more 
likely to desire no more children (adjusted PR: 1.59; 95% CI: 1.33, 1.89). HIV-infected women 
were also less likely to know that IUC (adjusted PR 0.72; 95% CI: 0.61, 0.84) and the implant 
(adjusted PR 0.83; 95% CI: 0.75, 0.92) are safe during breastfeeding. Postpartum women strongly 
desire family spacing and many HIV-infected postpartum women desire no more children, 
suggesting an important role for these long-acting methods. Education about the efficacy and 
safety of IUC and the implant particularly during breastfeeding may facilitate postpartum use.
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Introduction
Prevention of unintended pregnancies is one of the four cornerstones of a comprehensive 
approach to the prevention of mother-to-child-transmission (PMTCT) of HIV (WHO, 
2009a). Both HIV infection and unintended pregnancies are common in sub-Saharan Africa, 
and have been associated with adverse maternal, perinatal, and infant outcomes (Hogan et 
al., 2010). Postpartum women tend to be particularly susceptible to unintended pregnancy in 
the first 3 to 6 months following delivery, as return to fertility is often unpredictable and 
lactational amenorrhea is not always strictly observed (Romero-Gutierrez, Vaca-Ortiz, 
Ponce-Ponce de Leon, & Lopez-Martinez, 2007). Therefore, HIV-infected postpartum 
women who want to limit or space their pregnancies should know about and have access to 
the most effective methods of family planning.
The two most effective forms of reversible contraception are intrauterine contraception 
(IUC) and the subdermal implant. They are collectively known as long-acting reversible 
contraception (LARC) as they are effective from three to twelve years. LARC is safe and 
highly effective in HIV-infected women stable on antiretroviral therapy (ART), with 
contraceptive failure rates of less than 1% (WHO, 2009b; Trussell, 2011; Winner et al., 
2012). In Malawi, 13% of women aged 15-49 years are infected with HIV, and are eligible 
for lifelong combination ART if pregnant, breastfeeding, WHO Stage III or IV, or with CD4 
count less than 500 cells/mm3 (Malawi Ministry of Health, 2011). Although 41% of all 
pregnancies are unintended, fewer than 3% of sexually active Malawian women aged 15-49 
years have ever used either LARC method (NSO, 2011). This is due, in part, to shortages of 
LARC methods and specially trained staff. Evaluating the level of knowledge and interest 
women have about these methods in the setting of currently limited access can inform 
educational interventions and policy changes to increase LARC demand and supply, which 
may help to decrease unintended pregnancy rates.
Evidence of possible interactions between ART and hormonal contraception have been 
reported in recent years (Robinson, Jamshidi, & Burke, 2012), while the depot 
medroxyprogesterone acetate (DMPA) injection has been recommended by the Malawi 
Ministry of Health as the “best hormonal contraception for women on ART and/or TB 
treatment” since 2011 (Malawi Ministry of Health, 2011). We therefore expected that HIV-
infected women would have lower levels of LARC knowledge compared to HIV-uninfected 
women as a result of biased counseling on family planning methods to reflect national 
guidelines.
Little is known about LARC knowledge, LARC interest, and the reproductive intentions of 
postpartum and HIV-infected women in sub-Saharan Africa. Nor is it known whether HIV 
status will remain an important factor as ART is brought to scale with better health and 
survival for HIV-infected women. Therefore, the objectives of this study were to describe 
the most recent pregnancy intentions and family planning preferences of HIV-infected and 
O'SHEA et al. Page 2






















HIV-uninfected postpartum Malawian women, and to assess whether HIV status is 
associated with fertility desire and knowledge of intrauterine contraception and the 
subdermal implant.
Methods
Study design and population
This was a cross-sectional evaluation of the baseline characteristics of women enrolled in a 
prospective cohort study of LARC uptake among postpartum Malawian women. Women 
were recruited from the postpartum unit of Bwaila Hospital, a government hospital in 
Lilongwe with over 15,000 deliveries a year, including 1,800 (12%) among HIV-infected 
women. Antenatal group counseling on family planning is routinely provided at the site 
where patients also receive individualized attention. While interval LARC insertion 
(insertion after the 6-week postpartum period) is also offered at the study site, postpartum 
women are not routinely offered LARC prior to discharge. Therefore, questions concerning 
interest in immediate postpartum LARC insertion were hypothetical.
Two research assistants fluent in English and Chichewa, the most commonly spoken local 
language, completed participant recruitment, enrollment, consenting and survey 
administration. All postpartum women were approached in the postpartum wards and 
informed about the study. Interested women were screened in a private area for eligibility. 
Inclusion criteria were: (a) current admission to the postpartum ward at Bwaila Hospital, (b) 
age 18-45 years, (c) live birth ≥28 weeks gestational age within the past 4 weeks, (d) fluency 
in English or Chichewa, (3) access to a working phone number and willingness to be 
contacted by phone for up to one year postpartum.
Eligible women underwent the informed consent process, and completed a 30-minute 
baseline survey focusing on participants’ demographics, reproductive health history, most 
recent pregnancy intention, family planning preferences, and knowledge of LARC. 
Participants were also asked about antenatal counseling on LARC and general interest in 
IUC or the implant. Those responding affirmatively were asked about interest in immediate 
postpartum insertion of the method. HIV status was determined by verifying the participant's 
health passport with the participant's permission, as HIV testing is routinely done as part of 
antenatal care in Malawi.
Survey instrument
Survey questions were developed based on previous studies assessing LARC knowledge and 
interest as well as items from the Malawian Demographic Health Survey (Crede et al., 2012; 
Natinoal Statistical Office, 2011; Todd et al., 2012). In the survey, we clarified that condoms 
can be considered a family planning method when used to prevent pregnancy. ‘Pregnancy 
intention’ was based on a response to the question, “At the time you got pregnant with your 
new baby, did you want to want to become pregnant then, did you want to wait until later, or 
did you want no more children at all?” ‘Fertility desire’ was defined as a response of one or 
greater children when asked how many children participants would like in the future. The 
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survey was piloted with the first nine participants and modified where necessary (see 
Supplementary File 1, survey).
Study sampling and sample size
The sample size (N=630) was based on a power calculation for the outcome of interest in the 
main cohort analysis (knowledge of both LARC methods) comparing HIV-infected women 
and HIV-uninfected women. We recruited HIV-infected and HIV-uninfected women at a 1:2 
ratio. All eligible HIV-infected patients and up to five eligible HIV-uninfected patients were 
recruited per day.
Statistical analysis
All study data were double-entered into a secure Research Electronic Data Capture 
(REDCap) study database by the two research assistants (Harris et al., 2009). The REDCap 
data were then exported and analyzed using Stata Version 13.0 (StataCorp, College Station, 
TX).
Descriptive statistics were calculated for categorical variables, and the Student's t-test was 
used to compare continuous variables by HIV status. Pearson's chi-square test was used to 
compare distributions of categorical variables by HIV status. A two-sided p-value of 0.05 
was considered statistically significant for all comparisons.
Modified Poisson regression with robust variance to estimate prevalence ratios was 
performed to evaluate the association between HIV status and the outcomes of fertility 
desire, knowledge of the safety and efficacy of LARC, and antenatal counseling on LARC. 
A fully adjusted model included education, age, number of living children, and 
socioeconomic status, which we hypothesized were possible confounders of HIV status and 
fertility-related outcomes. We adjusted the final model for age and number of living children 
following stepwise backward elimination of terms whose removal resulted in a <10% 
change in the primary regression coefficient.
Confidentiality assurances/Ethical considerations
Paper data were stored in locked file cabinets in a locked study office. Surveys were 
identified only by study ID number. Ethical approval was obtained from the University of 
North Carolina Institutional Review Board (IRB) and the National Health Sciences Research 
Committee of the Malawi Ministry of Health.
Results
Of 799 women screened between May and October 2013, 634 (79%) were eligible for study 
participation. The most common reason for exclusion was lack of access to a working phone 
(15%). All eligible women gave consent to participate in the study.
Demographic characteristics
Our analysis included 210 HIV-infected and 424 HIV-uninfected women (Table 1). HIV-
infected participants were more likely to be at least 25 years of age and older than HIV-
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uninfected participants (67% vs. 45%, p<0.001) and were less likely to have completed 
primary school or beyond (64% vs. 75%, p=0.004). Nearly all (94%) participants were 
married, with no significant difference by HIV status. Most participants reported having 
trouble obtaining food, clothing, or medications, though a greater proportion of HIV-
infected participants reported difficulty with at least one item (62% vs. 52%, p=0.02).
Pregnancy intention and family planning preferences
HIV-infected participants were more likely to report their most recent pregnancy was 
unintended (49% vs. 37%, p=0.004), and to have been using contraception at the time of 
conception (30% vs. 20%, p=0.005)(Table 1). Of those using contraception at conception, 
the most commonly reported methods used were injectables and condoms. Many 
participants reported using more than one method, though a greater proportion of HIV-
infected participants reported using condoms (63% vs. 34%, p<0.001), dual method use with 
condoms (32% vs. 12%, p=0.003), and LARC methods (10% vs. 2%, p=0.06). While 50 
women (34%) were using multiple modern methods, 30 (20%) were using condoms with 
another method.
Future contraceptive choices of participants varied slightly between the two groups, with 
HIV-infected participants more likely to plan to use condoms, female sterilization, and male 
sterilization, and less likely to use natural family planning, withdrawal, and oral 
contraceptives (Table 1). The most common methods planned between both groups were 
breastfeeding (73%), the implant (67%), and condoms (42%). Of HIV-infected women, 53% 
reported plans to use condoms and another modern method of family planning, compared 
with 35% of HIV-uninfected women (p<0.001).
The two groups did not differ in interest in the implant or IUC. A majority (81%) of 
participants were interested in using the implant, while 19% were interested in immediate 
postpartum implant. 52% of participants were interested in IUC whereas 12% were 
interested in immediate postpartum IUC insertion.
HIV status and future fertility desire
Nearly all participants (97%) did not want to become pregnant again in the next 2 years, and 
HIV-infected participants were more likely to desire no more children (59% vs. 26%, 
p<0.001)(Table 1). In multivariable analysis, HIV-infected participants were over 50% more 
likely to desire no further children (adjusted PR: 1.59; 95% CI: 1.33, 1.89) when adjusted 
for age and number of living children (Table 3). Other independent predictors of desire for 
no further children included having more than two living children (adjusted PR: 4.64; 95% 
CI: 2.86, 7.54) and age over 30 years (adjusted PR: 2.57; 95% CI: 1.92, 3.44).
HIV status and knowledge of long-acting reversible contraception
While nearly all HIV-infected and HIV-uninfected women had heard of the implant (99% 
vs. 97%, p=0.06) and IUC (98% vs. 89%, p<0.001), general knowledge of either LARC 
method was low. HIV-infected status was associated with lower levels of knowledge of 
LARC safety in breastfeeding (IUC: 50% vs 69%, p<0.001; Implant: 69% vs. 82%, 
p<0.001)(Table 2). Nearly all (99%) participants had at least one knowledge gap regarding 
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the safety and efficacy of IUC, compared to 77% with the implant. In multivariable 
analyses, when adjusted for age and number of living children, HIV-infected status was 
independently associated with lower levels of knowledge of IUC safety during breastfeeding 
(adjusted PR: 0.72; 95% CI: 0.61, 0.84) and lower levels of knowledge of implant safety 
during breastfeeding (adjusted PR: 0.83; 95% CI: 0.75, 0.92)(Table 3). HIV-infected status 
was also independently associated with having received antenatal counseling about LARC 
(adjusted PR 1.19; 95% CI 1.10, 1.30). Antenatal counseling on LARC was not associated 
with LARC knowledge in multivariable analyses except in the case of IUC safety in 
breastfeeding, in which IUC counseling was associated with lower levels of knowledge of 
its safety in breastfeeding (adjusted PR 0.79; 95% CI 0.60, 0.82).
Discussion
In this population of postpartum Malawian women, HIV-infected women were more likely 
to report that their most recent pregnancy was unintended, and more likely to desire no more 
children. Study participants had generally low levels of knowledge regarding the safety and 
efficacy of LARC, and HIV-infected women were less likely to know that LARC was safe 
to use during breastfeeding. Improved strategies are needed to appropriately counsel HIV-
infected women about the most effective forms of postpartum contraception while ensuring 
consistent access to LARC methods to prevent future unintended pregnancies.
Attitudes towards reproduction among HIV-infected women are complex, given the conflict 
between cultural norms encouraging childbearing and social disapproval of childbearing 
among HIV-infected women (Cooper et al., 2007). Unintended pregnancy was common in 
our population, in which half of HIV-infected participants reported that their last pregnancy 
was unintended. Unintended pregnancy was also higher among HIV-infected women in 
Zimbabwe (McCoy et al., 2014), while most recent pregnancy intentions of postpartum 
women in South Africa and Swaziland did not differ by HIV status (Warren, Abuya, Askew, 
& Integra, 2013). Most of our HIV-infected women also did not want to have more children. 
HIV-infected women in sub-Saharan Africa tend to have lower fertility desire (Bankole, 
Biddlecom, & Dzekedzeke, 2011; Sarnquist, Rahangdale, & Maldonado, 2013; Taulo et al., 
2009). In Uganda, the most commonly cited reason for lack of desire for future children was 
the impact of HIV on the mother and the risk of transmission to the child (Heys, 2012). 
However, this is not always the case, and many HIV-infected women in sub-Saharan Africa 
also continue to desire children (Cooper et al., 2007; Homsy et al., 2009; Maier et al., 2009; 
Myer, Morroni, & Rebe, 2007; Nakayiwa et al., 2006), though studies comparing HIV-
infected and HIV-uninfected women have reported mixed results. HIV-infected women 
continued to desire children equal to HIV-uninfected women in South Africa (Cooper et al., 
2007), but were less likely to desire more children in Rwanda and South Africa (Kaida et al., 
2011). In Malawi, knowledge of HIV status among monogamous couples increased desire to 
limit childbearing (Dube et al., 2012), while younger age, less advanced WHO clinical stage 
at ART initiation, and longer time on ART have been associated with increased actual 
fertility among women on ART (Tweya et al., 2013).
We did not record date of HIV diagnosis, WHO clinical stage or ART status, which have 
shown variable association with fertility desire in Uganda, Tanzania, and South Africa 
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(Kaida et al., 2011; Maier et al., 2009; Mmbaga, Leyna, Ezekiel, & Kakoko, 2013; Myer et 
al., 2007). Notably, according to the July-September 2013 Integrated HIV Program Report 
produced by the Malawi Ministry of Health, 75% of HIV-infected pregnant women were on 
ART during that quarter, coinciding with the time period in which most of the women 
completed this survey (Malawi Ministry of Health, 2013). Finally, we do not know how 
participants’ fertility desires will translate to reproductive behavior, as partners’ conflicting 
desires may affect contraceptive use (Hossain, Phillips, & Mozumder, 2007).
Many of our participants whose last pregnancy was unintended reported using condoms or 
the injectable at time of conception, consistent with previously-documented contraceptive 
patterns in the region (Kaida et al., 2010; Myer et al., 2010). This finding may be related to 
condoms and injectables having 1-year failure rates of 18% and 6%, respectively with 
typical use in industrialized countries (Trussell, 2011), and typical use in Malawi may be 
even worse. While dual method use with condoms was low, there was considerable overlap 
between injectables and oral contraceptives, which may result from method switching due to 
inconsistent supply of preferred short-term methods. Nearly all postpartum women did not 
desire another pregnancy in the next two years, though fewer women planned to use a 
contraceptive method that would be effective for a full two years. Given the emphasis of the 
Malawian Ministry of Health on DMPA in HIV-infected women and recent evidence of 
interactions between ART and hormonal contraception, further research is needed to 
establish the most effective contraceptive methods for this population.
Despite high levels of LARC interest, general knowledge of the safety and efficacy of 
LARC was low. Important misconceptions included the belief that LARC is unsafe in 
breastfeeding women and in HIV-infected women, similar to beliefs held by HIV-infected 
and HIV-uninfected women in South Africa (Crede et al., 2012). Overall, postpartum 
Malawian women knew less about IUC than the implant. In Ethiopia and Uganda, women 
were least knowledgeable of IUC and most knowledgeable of the implant and injectables 
(Anguzu et al., 2014; Tilahun et al., 2013). Provider misperceptions and biases may also 
account for the gap between counseling and knowledge. Health providers in Kenya and 
South Africa reported perceiving IUC as unsafe for HIV-infected women and were 
uncomfortable recommending IUC to HIV-infected patients (Gutin, Mlobeli, Moss, Buga, & 
Morroni, 2011; Newmann et al., 2013). These misunderstandings offer potential targets for 
educational interventions to increase LARC demand and uptake, which have been found to 
be effective in other settings (Lewis, Darney, & Thiel de Bocanegra, 2013; Secura, 
Allsworth, Madden, Mullersman, & Peipert, 2010). Such efforts must be coupled with 
policy changes ensuring LARC access, including training health care staff in IUC and 
implant insertions, and ensuring consistent supply of LARC commodities and equipment.
Our study has several limitations. First, the cross-sectional design restricts our ability to 
determine causal relationships between HIV status and LARC knowledge and fertility 
desire. As we relied on self-reported data, we may have encountered social desirability bias, 
which could have inflated reports of LARC interest, contraceptive use, condom use, and 
desire to limit fertility, particularly among HIV-infected women. Participants may have also 
had varying ability to recall aspects of personal history such as antenatal counseling. A 
potentially significant number of women were excluded due to lack of phone access, which 
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may have also led to sampling bias excluding the most socioeconomically disadvantaged 
Malawians. Nonetheless, the family planning preferences reported are generally consistent 
with results from the most recent Malawi Demographic and Health Survey and likely 
reflective of a population that experiences both high HIV incidence and high fertility (NSO, 
2011).
In conclusion, HIV-infected postpartum women in Malawi have high rates of most recent 
unintended pregnancy, desire to limit future childbearing, and have low knowledge about 
LARC. These findings underscore a need to improve efforts to integrate family planning and 
HIV services to decrease unintended pregnancies among HIV-infected women and mother-
to-child- transmission of HIV (Wilcher, Hoke, Adamchak, & Cates, 2013). Evidence-based 
strategies to improve knowledge, access, and uptake of the most effective forms of 
contraception are needed to adequately address the stated reproductive goals of this 
population.
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Table 1







N (%) N (%) N (%) p-value
Age
18-24 68 (32) 232 (55) 300 (47)
25-34 116 (55) 169 (40) 285 (45)




Married 195 (93) 403 (95) 598 (94)
Unmarried 15 (7) 21 (5) 36 (6) 0.3
Education
None or some primary 76 (36) 104 (25) 180 (28)
Primary/some secondary 90 (43) 195 (46) 285 (45)
Secondary and beyond 44 (21) 125 (29) 169 (27)
0.004
*
Trouble with food, clothing, or medications
Yes 130 (62) 222 (52) 352 (56)




1 49 (23) 195 (46) 244 (38)
2-3 105 (50) 167 (39) 272 (43)
≥4 56 (27) 62 (15) 118 (19)
<0.001
*
Number of additional children desired
0 124 (59) 108 (26) 232 (37)
1 58 (28) 160 (38) 218 (35)
≥2 23 (11) 148 (35) 171 (27)
Don't know 4 (2) 6 (1) 10 (2)
<0.001
*
Desire additional pregnancy in 2 years
Yes 3 (1) 13 (3) 16 (3)
No 207 (99) 408 (96) 615 (97)
Don't know 0 (0) 3 (1) 3 (<1) 0.2
Most recent pregnancy intention
Intended 107 (51) 268 (63) 375 (59)
Unintended 102 (49) 156 (37) 258 (41)
0.004
*
Using contraception during conception
Yes 63 (30) 85 (20) 148 (23)




Contraceptive used during conception
b





























N (%) N (%) N (%) p-value
Abstinence 3 (5) 11 (13) 14 (10) 0.09
Folk method 0 (0) 2 (2) 2 (1) 0.2
Natural family planning 10 (16) 19 (22) 29 (20) 0.3
Withdrawal 8 (13) 13 (15) 21 (14) 0.7
Breastfeeding 24 (38) 19 (22) 43 (29)
0.04
*
Condoms 40 (63) 29 (34) 69 (47)
<0.001
*
Condoms only 20 (32) 19 (22) 39 (26) 0.2
Condoms + modern method 20 (32) 10 (12) 30 (20)
0.003
*
Emergency contraception 0 (0) 0 (0) 0 (0) N/A
Oral contraceptives (OC) 17 (27) 21 (25) 38 (26) 0.8
Injectables 36 (57) 56 (66) 92 (62) 0.3
OC + injectables 11 (17) 14 (16) 25 (17) 0.9
LARC 6 (10) 2 (2) 8 (5) 0.06
Female sterilization 0 (0) 1 (1) 1 (1) 0.4




Abstinence 41 (20) 98 (23) 139 (22) 0.3
Natural family planning 17 (8) 77 (18) 94 (15)
0.001
*
Withdrawal 3 (1) 56 (13) 59 (9)
<0.001
*
Breastfeeding 145 (69) 320 (76) 465 (73) 0.09
Condoms 112 (53) 153 (36) 265 (42)
<0.001
*
Condoms + modern method 111 (53) 147 (35) 258 (41)
<0.001
*
Emergency contraception 2 (1) 15 (4) 17 (3) 0.06
Oral contraceptives 10 (5) 55 (13) 65 (10)
0.001
*
Injectables 76 (36) 162 (38) 238 (38) 0.6
Implant 135 (64) 292 (69) 427 (67) 0.2
IUC 43 (21) 82 (19) 125 (20) 0.7
Female sterilization 53 (25) 44 (10) 97 (15)
<0.001
*
Male sterilization 3 (1) 0 (0) 3 (<1)
0.01
*




Columns may not add up to total N as ‘don't know,’ inappropriate responses, and nonresponses were excluded.
b
Columns may not add up to 100% as participants were able to select multiple methods.
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Table 2
Knowledge of Intrauterine Contraception and Subdermal Implant by HIV Status
HIV-infected (N=210) HIV-uninfected (N=424) All women (N=634) Pearson Chi2 p-value
N (%) N (%) N (%)
Heard of IUC
    Yes 206 (98) 377 (89) 583 (92)




a (N=206) (N=377) (N=583)
Knowledge of IUC efficacy (compared with injection)
    More effective 100 (49) 195 (52) 295 (51)
    Less effective 26 (13) 51 (14) 77 (13)
    Equally effective 6 (3) 14 (4) 20 (3)
    Don't know 74 (36) 115 (31) 189 (33) 0.6
Knowledge of IUC safety
    Safe 130 (63) 224 (60) 354 (61)
    Unsafe/Don't know 75 (37) 151 (40) 226 (39) 0.4
Knowledge of IUC safety in HIV-infected women
    Safe 85 (42) 173 (46) 258 (45)
    Unsafe/Don't know 116 (58) 203 (54) 319 (55) 0.4
Knowledge of IUC safety in breastfeeding
    Safe 101 (50) 260 (69) 361 (62)
    Unsafe/Don't know 103 (50) 117 (31) 220 (38)
<0.001
*
Does IUC cause infertility?
    No 159 (78) 265 (71) 424 (73)
    Yes/Don't know 46 (22) 110 (29) 156 (27) 0.07
Knowledge of maximum duration of IUC
    0-5 years 93 (46) 191 (51) 284 (49)
    5-10 years 22 (11) 31 (8) 53 (9)
    >10 years 3 (1) 5 (1) 8 (1)
    Don't know 85 (42) 147 (39) 232 (40) 0.6
Heard of implant
    Yes 209 (99) 410 (97) 619 (98)
    No 1 (1) 11 (3) 12 (2) 0.06
Implant knowledge
a (N=209) (N=410) (N = 619)
Knowledge of implant efficacy (compared to injection)
    More effective 171 (82) 335 (82) 506 (82)
    Less effective 18 (9) 18 (4) 36 (6)
    Equally effective 8 (4) 22 (5) 30 (5)
    Don't know 11 (5) 35 (9) 46 (7) 0.07
Knowledge of implant safety
    Safe 179 (87) 354 (88) 533 (88)
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HIV-infected (N=210) HIV-uninfected (N=424) All women (N=634) Pearson Chi2 p-value
N (%) N (%) N (%)
    Unsafe/Don't know 26 (13) 50 (12) 76 (12) 0.9
Knowledge of implant safety in HIV-infected women
    Safe 127 (62) 272 (66) 399 (65)
    Unsafe/Don't know 79 (38) 137 (34) 216 (35) 0.2
Knowledge of implant safety in breastfeeding
    Safe 144 (69) 336 (82) 480 (78)
    Unsafe/Don't know 65 (31) 73 (18) 138 (22)
<0.001
*
Does the implant cause infertility?
    No 187 (90) 337 (82) 524 (85)
    Yes/Don't know 21 (10) 71 (18) 92 (15)
0.02
*
Knowledge of maximum implant duration
    0-2 years 1 (1) 4 (1) 5 (1)
    3-5 years 179 (86) 329 (81) 508 (83)
    >5 years 14 (7) 39 (10) 53 (9)




Observations for IUC and implant knowledge include only responses of those reporting awareness of either method and exclude inappropriate 
responses and nonresponses.
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Table 3
Association between HIV-infected Status and Outcomes of Fertility Desire, Intrauterine Contraception 
Knowledge, and Implant Knowledge
N
a Unadjusted PR (95% CI) Adjusted PR
b (95% CI)
Do not want more children
c 634 2.32 (1.90 2.83) 1.59 (1.33 1.89)
IUC knowledge
    Safety of IUC in breastfeeding 581 0.72 (0.62 0.84) 0.72 (0.61 0.84)
    Safety of IUC in HIV-infected 577 0.92 (0.76 1.12) 0.93 (0.76 1.14)
    Efficacy of IUC 581 0.93 (0.79 1.11) 0.92 (0.77 1.10)
Implant knowledge
    Safety of implant in breastfeeding 618 0.84 (0.76 0.93) 0.83 (0.75 0.92)
    Safety of implant in HIV-infected 615 0.93 (0.82 1.05) 0.93 (0.82 1.06)
    Efficacy of implant 618 1.01 (0.93 1.09) 1.01 (0.93 1.09)
Antenatal counseling on IUC and the implant 634 1.24 (1.14 1.34) 1.19 (1.10 1.30)
PR=prevalence ratio, CI=confidence interval, IUC=intrauterine contraception
a
Observations for IUC and implant knowledge include only responses of those reporting awareness of the method and exclude inappropriate 
responses and nonresponses.
b
Adjusted for age and number of living children.
c
HIV-infected women were 1.59 times more likely to not want more children when adjusted for age and number of living children.
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